-+ 0.00%
-+ 0.00%
-+ 0.00%

CYTOKINETICS ANNOUNCES HEALTH CANADA APPROVAL OF MYQORZO® (AFICAMTEN) FOR THE TREATMENT OF ADULTS WITH SYMPTOMATIC OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY

Reuters·10/19/2026 11:30:00

Please log in to view news